 | • レポートコード：MRC2Q12-17147 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、コラーゲン止血剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 コラーゲン止血剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 コラーゲン止血剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 コラーゲン止血剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのコラーゲン止血剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のコラーゲン止血剤の売上および2028年までの予測に焦点を当てています。 コラーゲン止血剤のグローバル主要企業には、BD、SYMATESE、Johnson & Johnson、Gelita、3M、Angelini Pharma、Medline Industries、Integra LifeSciences、BSN Medical、Coloplast、Covalon Technologie、Aroa Biosurgery、AMERXなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 コラーゲン止血剤市場は、タイプとアプリケーションによって区分されます。世界のコラーゲン止血剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ミクロフィブリルコラーゲン止血剤、ネイティブコラーゲン止血剤 【アプリケーション別セグメント】 病院、診療所、家庭用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - コラーゲン止血剤製品概要 - タイプ別市場（ミクロフィブリルコラーゲン止血剤、ネイティブコラーゲン止血剤） - アプリケーション別市場（病院、診療所、家庭用） - 調査の目的 ・エグゼクティブサマリー - 世界のコラーゲン止血剤販売量予測2017-2028 - 世界のコラーゲン止血剤売上予測2017-2028 - コラーゲン止血剤の地域別販売量 - コラーゲン止血剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別コラーゲン止血剤販売量 - 主要メーカー別コラーゲン止血剤売上 - 主要メーカー別コラーゲン止血剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ミクロフィブリルコラーゲン止血剤、ネイティブコラーゲン止血剤） - コラーゲン止血剤のタイプ別販売量 - コラーゲン止血剤のタイプ別売上 - コラーゲン止血剤のタイプ別価格 ・アプリケーション別市場規模（病院、診療所、家庭用） - コラーゲン止血剤のアプリケーション別販売量 - コラーゲン止血剤のアプリケーション別売上 - コラーゲン止血剤のアプリケーション別価格 ・北米市場 - 北米のコラーゲン止血剤市場規模（タイプ別、アプリケーション別） - 主要国別のコラーゲン止血剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのコラーゲン止血剤市場規模（タイプ別、アプリケーション別） - 主要国別のコラーゲン止血剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のコラーゲン止血剤市場規模（タイプ別、アプリケーション別） - 主要国別のコラーゲン止血剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のコラーゲン止血剤市場規模（タイプ別、アプリケーション別） - 主要国別のコラーゲン止血剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのコラーゲン止血剤市場規模（タイプ別、アプリケーション別） - 主要国別のコラーゲン止血剤市場規模（トルコ、サウジアラビア） ・企業情報 BD、SYMATESE、Johnson & Johnson、Gelita、3M、Angelini Pharma、Medline Industries、Integra LifeSciences、BSN Medical、Coloplast、Covalon Technologie、Aroa Biosurgery、AMERX ・産業チェーン及び販売チャネル分析 - コラーゲン止血剤の産業チェーン分析 - コラーゲン止血剤の原材料 - コラーゲン止血剤の生産プロセス - コラーゲン止血剤の販売及びマーケティング - コラーゲン止血剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - コラーゲン止血剤の産業動向 - コラーゲン止血剤のマーケットドライバー - コラーゲン止血剤の課題 - コラーゲン止血剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Collagen Hemostat is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Collagen Hemostat is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Collagen Hemostat is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Collagen Hemostat include BD, SYMATESE, Johnson & Johnson, Gelita, 3M, Angelini Pharma, Medline Industries, Integra LifeSciences and BSN Medical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Collagen Hemostat manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Collagen Hemostat market. Further, it explains the major drivers and regional dynamics of the global Collagen Hemostat market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
BD
SYMATESE
Johnson & Johnson
Gelita
3M
Angelini Pharma
Medline Industries
Integra LifeSciences
BSN Medical
Coloplast
Covalon Technologie
Aroa Biosurgery
AMERX
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Collagen Hemostat Segment by Type
Microfibrillar Collagen Hemostat
Native Collagen Hemostat
Collagen Hemostat Segment by Application
Hospital
Clinic
Home
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Collagen Hemostat market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Collagen Hemostat, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Collagen Hemostat, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Collagen Hemostat, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Collagen Hemostat sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Collagen Hemostat market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Collagen Hemostat sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BD, SYMATESE, Johnson & Johnson, Gelita, 3M, Angelini Pharma, Medline Industries, Integra LifeSciences and BSN Medical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Collagen Hemostat in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Collagen Hemostat manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Collagen Hemostat sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Collagen Hemostat Product Introduction
1.2 Market by Type
1.2.1 Global Collagen Hemostat Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microfibrillar Collagen Hemostat
1.2.3 Native Collagen Hemostat
1.3 Market by Application
1.3.1 Global Collagen Hemostat Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Collagen Hemostat Sales Estimates and Forecasts 2017-2028
2.2 Global Collagen Hemostat Revenue Estimates and Forecasts 2017-2028
2.3 Global Collagen Hemostat Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Collagen Hemostat Sales by Region
2.4.1 Global Collagen Hemostat Sales by Region (2017-2022)
2.4.2 Global Sales Collagen Hemostat by Region (2023-2028)
2.5 Global Collagen Hemostat Revenue by Region
2.5.1 Global Collagen Hemostat Revenue by Region (2017-2022)
2.5.2 Global Collagen Hemostat Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Collagen Hemostat Sales by Manufacturers
3.1.1 Global Top Collagen Hemostat Manufacturers by Sales (2017-2022)
3.1.2 Global Collagen Hemostat Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Collagen Hemostat in 2021
3.2 Global Collagen Hemostat Revenue by Manufacturers
3.2.1 Global Collagen Hemostat Revenue by Manufacturers (2017-2022)
3.2.2 Global Collagen Hemostat Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Collagen Hemostat Revenue in 2021
3.3 Global Collagen Hemostat Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Collagen Hemostat Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Collagen Hemostat Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Collagen Hemostat Sales by Type
4.1.1 Global Collagen Hemostat Historical Sales by Type (2017-2022)
4.1.2 Global Collagen Hemostat Forecasted Sales by Type (2023-2028)
4.1.3 Global Collagen Hemostat Sales Market Share by Type (2017-2028)
4.2 Global Collagen Hemostat Revenue by Type
4.2.1 Global Collagen Hemostat Historical Revenue by Type (2017-2022)
4.2.2 Global Collagen Hemostat Forecasted Revenue by Type (2023-2028)
4.2.3 Global Collagen Hemostat Revenue Market Share by Type (2017-2028)
4.3 Global Collagen Hemostat Price by Type
4.3.1 Global Collagen Hemostat Price by Type (2017-2022)
4.3.2 Global Collagen Hemostat Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Collagen Hemostat Sales by Application
5.1.1 Global Collagen Hemostat Historical Sales by Application (2017-2022)
5.1.2 Global Collagen Hemostat Forecasted Sales by Application (2023-2028)
5.1.3 Global Collagen Hemostat Sales Market Share by Application (2017-2028)
5.2 Global Collagen Hemostat Revenue by Application
5.2.1 Global Collagen Hemostat Historical Revenue by Application (2017-2022)
5.2.2 Global Collagen Hemostat Forecasted Revenue by Application (2023-2028)
5.2.3 Global Collagen Hemostat Revenue Market Share by Application (2017-2028)
5.3 Global Collagen Hemostat Price by Application
5.3.1 Global Collagen Hemostat Price by Application (2017-2022)
5.3.2 Global Collagen Hemostat Price Forecast by Application (2023-2028)
6 North America
6.1 North America Collagen Hemostat Market Size by Type
6.1.1 North America Collagen Hemostat Sales by Type (2017-2028)
6.1.2 North America Collagen Hemostat Revenue by Type (2017-2028)
6.2 North America Collagen Hemostat Market Size by Application
6.2.1 North America Collagen Hemostat Sales by Application (2017-2028)
6.2.2 North America Collagen Hemostat Revenue by Application (2017-2028)
6.3 North America Collagen Hemostat Market Size by Country
6.3.1 North America Collagen Hemostat Sales by Country (2017-2028)
6.3.2 North America Collagen Hemostat Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Collagen Hemostat Market Size by Type
7.1.1 Europe Collagen Hemostat Sales by Type (2017-2028)
7.1.2 Europe Collagen Hemostat Revenue by Type (2017-2028)
7.2 Europe Collagen Hemostat Market Size by Application
7.2.1 Europe Collagen Hemostat Sales by Application (2017-2028)
7.2.2 Europe Collagen Hemostat Revenue by Application (2017-2028)
7.3 Europe Collagen Hemostat Market Size by Country
7.3.1 Europe Collagen Hemostat Sales by Country (2017-2028)
7.3.2 Europe Collagen Hemostat Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Collagen Hemostat Market Size by Type
8.1.1 Asia Pacific Collagen Hemostat Sales by Type (2017-2028)
8.1.2 Asia Pacific Collagen Hemostat Revenue by Type (2017-2028)
8.2 Asia Pacific Collagen Hemostat Market Size by Application
8.2.1 Asia Pacific Collagen Hemostat Sales by Application (2017-2028)
8.2.2 Asia Pacific Collagen Hemostat Revenue by Application (2017-2028)
8.3 Asia Pacific Collagen Hemostat Market Size by Region
8.3.1 Asia Pacific Collagen Hemostat Sales by Region (2017-2028)
8.3.2 Asia Pacific Collagen Hemostat Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Collagen Hemostat Market Size by Type
9.1.1 Latin America Collagen Hemostat Sales by Type (2017-2028)
9.1.2 Latin America Collagen Hemostat Revenue by Type (2017-2028)
9.2 Latin America Collagen Hemostat Market Size by Application
9.2.1 Latin America Collagen Hemostat Sales by Application (2017-2028)
9.2.2 Latin America Collagen Hemostat Revenue by Application (2017-2028)
9.3 Latin America Collagen Hemostat Market Size by Country
9.3.1 Latin America Collagen Hemostat Sales by Country (2017-2028)
9.3.2 Latin America Collagen Hemostat Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Collagen Hemostat Market Size by Type
10.1.1 Middle East and Africa Collagen Hemostat Sales by Type (2017-2028)
10.1.2 Middle East and Africa Collagen Hemostat Revenue by Type (2017-2028)
10.2 Middle East and Africa Collagen Hemostat Market Size by Application
10.2.1 Middle East and Africa Collagen Hemostat Sales by Application (2017-2028)
10.2.2 Middle East and Africa Collagen Hemostat Revenue by Application (2017-2028)
10.3 Middle East and Africa Collagen Hemostat Market Size by Country
10.3.1 Middle East and Africa Collagen Hemostat Sales by Country (2017-2028)
10.3.2 Middle East and Africa Collagen Hemostat Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Overview
11.1.3 BD Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BD Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BD Recent Developments
11.2 SYMATESE
11.2.1 SYMATESE Corporation Information
11.2.2 SYMATESE Overview
11.2.3 SYMATESE Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 SYMATESE Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 SYMATESE Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Gelita
11.4.1 Gelita Corporation Information
11.4.2 Gelita Overview
11.4.3 Gelita Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Gelita Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Gelita Recent Developments
11.5 3M
11.5.1 3M Corporation Information
11.5.2 3M Overview
11.5.3 3M Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 3M Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 3M Recent Developments
11.6 Angelini Pharma
11.6.1 Angelini Pharma Corporation Information
11.6.2 Angelini Pharma Overview
11.6.3 Angelini Pharma Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Angelini Pharma Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Angelini Pharma Recent Developments
11.7 Medline Industries
11.7.1 Medline Industries Corporation Information
11.7.2 Medline Industries Overview
11.7.3 Medline Industries Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medline Industries Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medline Industries Recent Developments
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Corporation Information
11.8.2 Integra LifeSciences Overview
11.8.3 Integra LifeSciences Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Integra LifeSciences Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Integra LifeSciences Recent Developments
11.9 BSN Medical
11.9.1 BSN Medical Corporation Information
11.9.2 BSN Medical Overview
11.9.3 BSN Medical Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BSN Medical Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BSN Medical Recent Developments
11.10 Coloplast
11.10.1 Coloplast Corporation Information
11.10.2 Coloplast Overview
11.10.3 Coloplast Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Coloplast Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Coloplast Recent Developments
11.11 Covalon Technologie
11.11.1 Covalon Technologie Corporation Information
11.11.2 Covalon Technologie Overview
11.11.3 Covalon Technologie Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Covalon Technologie Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Covalon Technologie Recent Developments
11.12 Aroa Biosurgery
11.12.1 Aroa Biosurgery Corporation Information
11.12.2 Aroa Biosurgery Overview
11.12.3 Aroa Biosurgery Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Aroa Biosurgery Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aroa Biosurgery Recent Developments
11.13 AMERX
11.13.1 AMERX Corporation Information
11.13.2 AMERX Overview
11.13.3 AMERX Collagen Hemostat Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 AMERX Collagen Hemostat Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 AMERX Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Collagen Hemostat Industry Chain Analysis
12.2 Collagen Hemostat Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Collagen Hemostat Production Mode & Process
12.4 Collagen Hemostat Sales and Marketing
12.4.1 Collagen Hemostat Sales Channels
12.4.2 Collagen Hemostat Distributors
12.5 Collagen Hemostat Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Collagen Hemostat Industry Trends
13.2 Collagen Hemostat Market Drivers
13.3 Collagen Hemostat Market Challenges
13.4 Collagen Hemostat Market Restraints
14 Key Findings in The Global Collagen Hemostat Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer